942133-13-3

Basic information

• Product Name: (2R,3S,E)-((1R,2S)-2-(N-benzyl-2,4,6-trimethylphenylsulfonamido)-1-phenylpropyl) 3-hydroxy-5-iodo-2,4-dimethylpent-4-enoate
• Synonyms: (2R,3S,E)-((1R,2S)-2-(N-benzyl-2,4,6-trimethylphenylsulfonamido)-1-phenylpropyl) 3-hydroxy-5-iodo-2,4-dimethylpent-4-enoate
• CAS NO: 942133-13-3
• Molecular Weight: 675.628
• Mol File: 942133-13-3.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: (2R,3S,E)-((1R,2S)-2-(N-benzyl-2,4,6-trimethylphenylsulfonamido)-1-phenylpropyl) 3-hydroxy-5-iodo-2,4-dimethylpent-4-enoate(CAS DataBase Reference)
• NIST Chemistry Reference: (2R,3S,E)-((1R,2S)-2-(N-benzyl-2,4,6-trimethylphenylsulfonamido)-1-phenylpropyl) 3-hydroxy-5-iodo-2,4-dimethylpent-4-enoate(942133-13-3)
• EPA Substance Registry System: (2R,3S,E)-((1R,2S)-2-(N-benzyl-2,4,6-trimethylphenylsulfonamido)-1-phenylpropyl) 3-hydroxy-5-iodo-2,4-dimethylpent-4-enoate(942133-13-3)

Safety Data

• Hazardous Substances Data: 942133-13-3(Hazardous Substances Data)

Upstream product

• 106484-89-3 (E)-3-iodo-2-methylprop-2-enal 
• 187324-66-9 (1R,2S)-2-(N-benzyl-N-mesitylenesulfonyl)amino-1-phenyl-1-propyl propionate 

Downstream Products

• 942133-26-8 (2R,3S,E)-((1R,2S)-2-(N-benzyl-2,4,6-trimethylphenylsulfonamido)-1-phenylpropyl) 5-iodo-3-methoxy-2,4-dimethylpent-4-enoate 
• 1190710-49-6 C₁₀H₁₈IO₅P 
• 187324-63-6 (1R,2S)-2-[N-benzyl-N-(mesitylenesulfonyl)amino]-1-phenyl-1-propanol 
• 1180131-47-8 (1R,2S)-2-[benzyl(mesitylsulfonyl)amino]-1-phenylpropyl-(2R,3S,4E)-5-iodo-2,4-dimethyl-3-[(triethylsilyl)oxy]pent-4-enoate 
• 1439376-71-2 (2R,3S,E)-((1R,2S)-2-(N-benzyl-2,4,6-trimethylphenylsulfonamido)-1-phenylpropyl)-3-(tert-butyldimethylsilyloxy)-5-iodo-2,4-dimethylpent-4-enoate 
• 1313046-81-9 C₃₆H₅₄F₃IO₉Si 
• 1313046-79-5 C₃₆H₅₄F₃IO₉Si 
• 1313046-77-3 C₂₄H₃₂O₆ 
• 1313046-75-1 C₃₄H₅₄O₈Si 
• 1313046-73-9 C₃₂H₅₂O₇Si 
• 942133-29-1 C₃₈H₆₁IO₆Si 
• 942133-19-9 (1E,6E,8Z,10Z,14E)-(3S,4R,12S,13S)-13-(tert-butyl-dimethyl-silanyloxy)-1-iodo-3-methoxy-17-(4-methoxy-benzyloxy)-2,4,8,10,12,15-hexamethyl-heptadeca-1,6,8,10,14-pentaen-5-one 

Relevant articles and documents

CERTAIN PLADIENOLIDE COMPOUNDS AND METHODS OF USE

The present disclosure provides novel pladienolide compounds, pharmaceutical compositions containing such compounds, and methods for using the compounds as therapeutic agents. These compounds may be useful in the treatment of cancers, particularly cancers in which agents that target the spliceosome and mutations therein are known to be useful. Also provided herein are methods of treating cancers by administering at least one compound disclosed herein and at least one additional therapy.

Divergent total synthesis of the antimitotic agent leiodermatolide

Subtle but distinctive: The stereostructure of the biologically highly promising antimitotic agent leiodermatolide was uncertain. A short, efficient, and flexible total synthesis based on ring-closing alkyne metathesis as the key step has now solved the p

Modular total synthesis of archazolid A and B

(Chemical Equation Presented) A modular total synthesis of the potent V-ATPase inhibitors archazolid A and B is reported. The convergent preparation was accomplished by late-stage diversification of joint intermediates. Key synthetic steps involve asymmetric boron-mediated aldol reactions, two consecutive Still-Gennari olefinations to set the characteristic (Z,Z)-diene system, a Brown crotyboration, and a diastereo-selective aldol condensation of highly elaborate intermediates. For macrocyclization, both an HWE reaction and a Heck coupling were successfully employed to close the 24-membered macrolactone. During the synthetic campaign, a generally useful protocol for an E-selective Heck reaction of nonactivated alkenes and a method for the direct nucleophilic displacement of the Abiko-Masamune auxiliary with sterically hindered nucleophiles were developed. The expedient and flexible strategy will enable further SAR studies of the archazolids and more detailed evaluations of target-inhibitor interactions. 2009 American Chemical Society.